Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients

Journal of Gastroenterology

Volumn 49, Issue 10, 2014, Pages 1414-1420

  Lammert, Craig ^a   Juran, Brian D ^a   Schlicht, Erik ^a   Chan, Landon L ^b   Atkinson, Elizabeth J ^b   de Andrade, Mariza ^b   Lazaridis, Konstantinos N ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

Autoimmune; Cholestasis; Outcomes; Toronto criteria

Indexed keywords

ALKALINE PHOSPHATASE; URSODEOXYCHOLIC ACID; BIOLOGICAL MARKER; CHOLAGOGUE;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASCITES; BRAIN DISEASE; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE REGISTRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; KAPLAN MEIER METHOD; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY; NORTH AMERICAN; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIMARY BILIARY CIRRHOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VARICOSIS; BLOOD; CHEMICALLY INDUCED; ENZYME ASSAY; LIVER CIRRHOSIS, BILIARY; PROCEDURES; PROGNOSIS; PRURITUS;

ALKALINE PHOSPHATASE; BIOMARKERS; CHOLAGOGUES AND CHOLERETICS; CLINICAL ENZYME TESTS; COHORT STUDIES; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; PROGNOSIS; PRURITUS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 84919469374     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-013-0903-1     Document Type: Article

References (18)

1. Gershwin ME, Mackay IR. The causes of primary biliary cirrhosis: convenient and inconvenient truths. Hepatology. 2008;47:737–45.
2. Hirschfield GM, Invernizzi P. Progress in the genetics of primary biliary cirrhosis. Semin Liver Dis. 2011;31:147–56.
3. Lindor KD, Gershwin ME, Poupon R, et al. Primary biliary cirrhosis. Hepatology. 2009;50:291–308.
4. Poupon RE, Balkau B, Eschwege E, et al. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med. 1991;324:1548–54.
5. Lindor KD, Therneau TM, Jorgensen RA, et al. Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology. 1996;110:1515–8.
6. Poupon RE, Bonnand AM, Chretien Y, et al. Ten-year survival in ursodeoxycholic acid-treated patients with primary biliary cirrhosis. The UDCA-PBC Study Group. Hepatology. 1999;29:1668–71.
7. Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010;52:745–58.
8. Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology. 2006;130:715–20.
9. Corpechot C, Abenavoli L, Rabahi N, et al. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatology. 2008;48:871–7.
10. Kuiper EM, Hansen BE, de Vries RA, et al. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009;136:1281–7.
11. Corpechot C, Chazouilleres O, Poupon R. Early primary biliary cirrhosis: biochemical response to treatment and prediction of long-term outcome. J Hepatol. 2011;55:1361–7.
12. Kumagi T, Guindi M, Fischer SE, et al. Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol. 2010;105:2186–94.
13. Lazaridis KN, Juran BD, Boe GM, et al. Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis. Hepatology. 2007;46:785–92.
14. Kalbfleisch J, Prentice R. The statistical analysis of failure time data. 2nd ed. Wiley: Interscience; 1980.
15. R Development Core Team. A language and environment for statistical computing. The R Project for Statistical Computing. 2011. http://www.r-project.org/.
16. Carbone M, Mells GF, Pells G, et al. Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid. Gastroenterology. 2013;144:560–9.
17. Ali AH, Sinakos E, Silveira MG, et al. Varices in early histological stage primary biliary cirrhosis. J Clin Gastroenterol. 2011;45:e66–71.
18. Huet PM, Vincent C, Deslaurier J, et al. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment. Gastroenterology. 2008;135:1552–60.